Telephone titration of heart failure medications

Journal of Cardiovascular Nursing

Volumn 26, Issue 1, 2011, Pages 29-36

  Steckler, Anne E ^a   Bishu, Kalkidan ^a   Wassif, Heba ^a   Sigurdsson, Gardar ^a   Wagner, Judy ^a   Jaenicke, Connie ^a   Vats, Shashank ^a   Rector, Thomas ^a   Anand, I S ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

Disease management; Heart failure; Nurse managed clinic; Telephone care

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; CARDIOVASCULAR NURSING; COUNSELING; FEMALE; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PROCEDURES; TELENURSING; TELEPHONE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR NURSING; COUNSELING; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; TELENURSING; TELEPHONE;

EID: 79951515597     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e3181ec1223     Document Type: Article

References (36)

1. National Heart, Lung and Blood Institute. Incidence and Prevalence: 2007 Chart Book on Cardiovascular and Lung Diseases. Bethesda, MD: National Institutes of Health; 2007:19.
2. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; the Rotterdam Study. Eur Heart J. 1999; 20:447Y455. (Pubitemid 29116541)
3. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344Y350. (Pubitemid 38944258)
4. American Heart Association. Heart Disease and Stroke StatisticsV2008 Update. Dallas, TX: American Heart Association; 2008:22.
5. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651Y1658. (Pubitemid 32479962)
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
7. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. (Pubitemid 29407370)
8. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
9. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321. (Pubitemid 36384098)
10. Cohn JN, Tognoni G. A randomized trial of the angiotensin- receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675. (Pubitemid 33126822)
11. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154Ye235.
12. Heart Failure Society of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12:e1Ye2.
13. Rector TS, Anand IS, Nelson DB, Ensrud KE. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure. J Am Geriatr Soc. 2008;56:1021-1027. (Pubitemid 351782709)
14. Lenzen MJ, Boersma E, Reimer WJ, et al. Underutilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J. 2005;26:2706-2713. (Pubitemid 41748284)
15. Fowler MB, Lottes SR, Nelson JJ, et al. beta-Blocker dosing in community-based treatment of heart failure. Am Heart J. 2007;153:1029-1036. (Pubitemid 46809843)
16. Cleland JG, Cohen-Solal A, Aguilar JC, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002;360:1631-1639. (Pubitemid 35379734)
17. Rich M. Heart failure disease management: a critical review. J Card Fail. 1999;5:64-75. (Pubitemid 29149090)
18. Kornowski R, Zeeli D, Averbuch M, et al. Intensive homecare surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J. 1995;129:762-766.
19. Lasater M. The effect of a nurse-managed CHF clinic on patient readmission and length of stay. Home Healthc Nurse. 1996;14:351-356.
20. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997;79:58-63. (Pubitemid 127673677)
21. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. (Pubitemid 41821197)
22. de Groote P, Isnard R, Assyag P, et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail. 2007;9:1205-1211. (Pubitemid 350153640)
23. Fonarow GC, Yancey CW, Albert NM, et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE-HF. Circ Heart Fail. 2008;1:98-106.
24. Franciosa JA, Massie BM, Lukas MA, et al. beta-Blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. Am Heart J. 2004; 148:718-726. (Pubitemid 39349394)
25. Gustafsson F, Schou M, Videbaek L, et al. Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure. Eur J Heart Fail. 2007;9:910-916. (Pubitemid 47332310)
26. Dunagan WC, Littenberg B, Ewald GA, et al. Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure. J Card Fail. 2005;11:358-365.
27. Ansari M, Shlipak MG, Heidenreich PA, et al. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 2003;107:2799-2804. (Pubitemid 36705989)
28. Moyer-Knox D, Mueller TM, Vuckovic K, Mischke L, Williams RE. Remote titration of carvedilol for heart failure patients by advanced practice nurses. J Card Fail. 2004;10:219-224. (Pubitemid 38869462)
29. Spaeder J, Najjar SS, Gerstenblith G, et al. Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. Am Heart J. 2006;151:844: e1Ye10.
30. Laramee AS, Levinsky SK, Sargent J, Ross R, Callas P. Case management in a heterogeneous congestive heart failure population: a randomized controlled trial. Arch Intern Med. 2003;163:809-817. (Pubitemid 36438053)
31. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355. (Pubitemid 26152713)
32. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342: 821-828.
33. Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146: 250-257. (Pubitemid 36951768)
34. Jost A, Rauch B, Hochadel M, et al. beta-Blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study. Eur Heart J. 2005;26:2689-2697. (Pubitemid 41746692)
35. Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 1996;94: 2807-2816. (Pubitemid 26411745)
36. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensinconverting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100:2312-2318.